Belgium· BE-AMP-SAM507520-00
Ivabradine Sandoz 5 mg
A ivabradine product containing ivabradine oxalate, registered in Belgium by Sandoz. The same ATC class is registered in 19 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ivabradine is registered in 19 of 19 countries.
Countries holding a registration under ATC C01EB17 (ivabradine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Ivabradine · ATC C01EB17
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ivabradine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in France to $1.75 in Switzerland — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ivabradine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.75
- ES Spain$1.17
- IT Italy$0.81
- FR France$0.59
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ivabradine Oxalate
- Manufacturer
- Sandoz
- Country
- Belgium (BE)
- ATC code
- C01EB17
- ATC class
- Ivabradine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7720402
- be_apb3605672
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for ivabradine.
Graded by severity as the source publishes them — 128 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ivabradine · interactions on record
203 records
- 128 severe
- 61 moderate
Most severe, free to view
- ClotrimazoleA01AB18severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
14 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ivabradine in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Ivabradin Sandoz, Ivacorlan
- Bulgaria · Ивабрадин Майлан
- Germany · Ivabradin Heumann
- Estonia · Brediwal, Ivabradine Viatris
- Spain · Ivabradina Viatris
- France · Ivabradine Sandoz, Ivabradine Viatris
- United Kingdom (Northern Ireland) · Ivabradine Chanelle Medical, Ivabradine Generics [uk]
- Italy · Ivabradina Mylan Pharma, Ivabradina Sandoz
- Lithuania · Ivabradine Ingen Pharma, Ivabradine Viatris
- Latvia · Ivabradine Viatris
- Netherlands · Ivabradine Chanelle Medical, Ivabradine Sandoz
- Poland · Ivabradine Viatris
- Portugal · Ivabradina Viatris
- Slovakia · Ivabradín Sandoz, Ivabradine Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/00e15219-4d0b-42e1-919e-ea18b9891426 GET /v1/drugs/00e15219-4d0b-42e1-919e-ea18b9891426?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Ivabradine Sandoz 5 mg",
"name_fr": "Ivabradine Sandoz 5 mg",
"name_nl": "Ivabradine Sandoz 5 mg",
"amp_code": "SAM507520-00",
"strengths": [
"5.9610",
"5.9610",
"5.0000",
"5.0000"
],
"pack_count": 24,
"substances": [
"Ivabradine Oxalate",
"Ivabradine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ivabradine",
"authorisation_numbers": [
"BE507520",
"BE507537",
"BE507546"
]
}See everything about ivabradine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.